AI-generated summary
The authors reviewed laboratory studies and randomized placebo-controlled trials of low-level laser therapy for acute soft-tissue injury pain. They report that most laboratory studies showed effects on inflammatory markers in a dose-dependent way, and that nine trials of acceptable quality were mostly favorable to light therapy over placebo. The authors state that further clinical trials with adequate doses are needed.
- Participants
- 609
- Studies included
- 9
- Who or what was studied
- Acute soft-tissue injury pain; laboratory studies in animals and cells, and randomized placebo-controlled clinical trials of acute soft-tissue injury
- Limits stated in the abstract
- The abstract notes poor and heterogeneous data presentation that hampered pooling of continuous data, and states that further trials are needed to precisely estimate effect size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Placebo-controlled, Low-level laser therapy, Systematic review, Laser, Dose, Confidence interval, Oxidative stress, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.